Cidofovir in the therapy and short-term prophylaxis of poxvirus infections

Henderson, 1998, Bioterrorism as a public health threat, Emerg. Infect. Dis., 4, 488, 10.3201/eid0403.980340 O'Toole, 1999, Smallpox: an attack scenario, Emerg. Infect. Dis., 5, 540, 10.3201/eid0504.990416 Cohen, 2001, Vaccines for biodefense: a system in distress, Science, 294, 498, 10.1126/science.294.5542.498 De Clercq, 1997, In search of a selective antiviral chemotherapy, Clin. Microbiol. Rev., 10, 674, 10.1128/CMR.10.4.674 De Clercq, 2001, Vaccinia virus inhibitors as paradigm for the chemotherapy of poxvirus infections, Clin. Microbiol. Rev., 14, 382, 10.1128/CMR.14.2.382-397.2001 Safrin, 1997, Clinical uses of cidofovir, Rev. Med. Virol., 7, 145, 10.1002/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0 Neyts, 1993, Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice, J. Med. Virol., 41, 242, 10.1002/jmv.1890410312 Smee, 2001, Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir, Antiviral Chem. Chemother., 12, 71, 10.1177/095632020101200105 Smee, 2001, Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, Antiviral Res., 52, 55, 10.1016/S0166-3542(01)00159-0 Bray, 2000, Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge, J. Infect. Dis., 181, 10, 10.1086/315190 Smee, 2000, Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir, Antiviral Chem. Chemother., 11, 303, 10.1177/095632020001100406 Smee, 2000, Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir, Antiviral Res., 47, 171, 10.1016/S0166-3542(00)00105-4 Bray, 2002, Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir, Antiviral Res., 54, 129, 10.1016/S0166-3542(01)00220-0 De Clercq, 2002, Cidofovir in the treatment of poxvirus infections, Antiviral Res., 55, 1, 10.1016/S0166-3542(02)00008-6 Kern, 2002, Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir, Antimicrob. Agents Chemother., 46, 991, 10.1128/AAC.46.4.991-995.2002 Huggins, J.W. et al. (2002) Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox. In Abstracts of the Fifteenth International Conference on Antiviral Research, Antiviral Res. 53, A67 (No. 104) Winegarden, K.L. et al. (2002) Oral pharmacokinetics and preliminary toxicology of 1-O-hexadecyloxypropyl-cidofovir in mice. In Abstracts of the Fifteenth International Conference on Antiviral Research, Antiviral Res. 53, A67 (No. 105) Meadows, 1997, Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir, Arch. Dermatol., 133, 987, 10.1001/archderm.133.8.987 Davies, 1999, Topical cidofovir for severe molluscum contagiosum, Lancet, 353, 2042, 10.1016/S0140-6736(99)01782-1 Zabawski, 1999, Topical cidofovir for molluscum contagiosum in children, Pediatr. Dermatol., 16, 414, 10.1046/j.1525-1470.1999.016005406.7.x Ibarra, 2000, Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient, Acta Derm. Venereol., 80, 315, 10.1080/000155500750012333 Toro, 2000, Topical cidofovir. A novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1, Arch. Dermatol., 136, 983, 10.1001/archderm.136.8.983 Geerinck, 2001, A case of human orf in an immunocompromised patient treated successfully with cidofovir cream, J. Med. Virol., 64, 543, 10.1002/jmv.1084 De Clercq, 1987, Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines, Antiviral Res., 8, 261, 10.1016/S0166-3542(87)80004-9 Redfield, 1987, Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease, New Engl. J. Med., 316, 673, 10.1056/NEJM198703123161106